Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus February 28, 2019https://clinicaltrials.gov/ct2/show/NCT02908100?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F14%2F2019&lupd_d=14 [Read more…] about Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
